Ewing sarcoma family of tumors share recurrent translocations that fuse EWS from 22q12 to ®ve dierent members of transcription factors namely FLI-1, ERG, ETV1, E1AF and FEV. Dierent classes of DNA binding proteins, ATF1, WT1 and CHOP are fused to EWS generating distinct tumor phenotypes: clear cell sarcoma, desmoplastic small round cell tumor, and myxoid liposarcoma, respectively. We have cloned a novel gene located at 22q12 fused to EWS by a submicroscopic inversion of 22q in a small round cell sarcoma showing a translocation (t(1;22)(p36.1;q12). The gene, designated ZSG (Zinc ®nger Sarcoma Gene), is a putative Cys 2 -His 2 zinc ®nger protein which contains a POZ transcriptional repressor-like domain at the Nterminus. The rearrangement involves intron 8 of EWS and exon 1 of ZSG creating a chimeric sequence containing the transactivation domain of EWS fused to zinc ®nger domain of ZSG. This product lacks the transcriptional repressor domain at the N-terminus of ZSG. A rearrangement of the second ZSG allele was also found in tumor cells. This is the ®rst example of an intra-chromosomal rearrangement of chromosome 22, undetectable by cytogenetics, activating EWS in soft tissue sarcoma. Oncogene (2000) 19, 3799 ± 3804.
We present here the ®rst report of an intrachromosomal rearrangement of chromosome 22 activating EWS by fusion with a novel zinc ®nger gene in a soft tissue sarcoma.
The tumor occurred in a male boy aged 16 years, presenting with a pulmonary metastasis 2 years after a primary tumor of the chest wall. Histologically both primary and metastatic tumors were highly suggesting for pPNET, possibly Askin-Rosai type owing to the primary site. Immunophenotyping performed on primary and metastatic tumor showed reactivity for synaptophysin (AO10, Dako) and NSE (MIG-N3, Sambio) and the same small clusters and scattered cells decorated with desmin (D33, Dako) and lowweight cytocheratins (CAM 5.2, Becton Dickinson). A negative staining was observed with neuro®laments (RPN1105, Amersham) and MIC2 antigen (013, Signet). The latter ®nding, being MIC2 a hallmark of pPNET, prompted the diagnosis of a small round cell tumor with multidirectional dierentiation rather than of pPNET.
Cytogenetic and¯uorescence in situ hybridization (FISH) analyses of the small round cell sarcoma under study revealed a translocation t(1;22)(p36.1;q12) (Figure 1a ± c) . No structural involvement of chromosome 11, indicative of the translocation t(11;22) described in 90% of Ewing's tumors (Turc-Carel et al., 1983) , (Sorensen et al., 1994) was observed.
To rule out a molecular fusion of EWS with already known partners, we performed RT ± PCR on tumor RNA to assess the presence of EWS/FLI-1 (May et al., 1993) , EWS/ERG (Sorensen et al., 1994) , EWS/FEV (Peter et al., 1997) , EWS/ETV (Jeon et al., 1995) , EWS/E1AF (Kaneko et al., 1996) , EWS/WT1 (Ladanyi and Gerald, 1994; Gerald et al., 1995) fusion products. We could not detect PCR products with any primer set (data not shown).
We tested the tumor DNA for the presence of EWS gene alterations by Southern blot analyses using as probe a partial EWS cDNA clone (Delattre et al., 1992 ). An abnormal restriction fragment was identi®ed in the tumor DNA with two enzyme digests indicating a rearrangement of the EWS gene (Figure 2a, upper panel) .
We hypothesized that a novel gene might be fused downstream to EWS as in the previously reported cases (Sorensen et al., 1994; May et al., 1993; Peter et al., 1997; Jeon et al., 1995; Kaneko et al., 1996; Ladanyi & Gerald, 1994; Gerald et al., 1995) and to this purpose we performed a 3'-RACE experiment. Two cDNA fragments of 1.5 and 0.7 kb, were isolated that contained EWS sequences as assayed by Southern blot analyses. Cloning and sequencing of these two transcripts revealed that the 1.5 kb PCR product was the wild-type EWS cDNA whereas the 0.7 kb product resulted an EWS chimeric transcript where EWS exon 8 was fused to a novel sequence coding for a classical zinc ®nger motif Cys 2 -His 2 (Figure 2b ). We designated this sequence ZSG (Zinc ®nger Sarcoma Gene). Using a forward primer for EWS exon 7 and a reverse primer in the ZSG sequence we con®rmed the presence of the hybrid transcript in tumor cDNA from the patient thus excluding cloning artefacts. The fusion breakpoint was mapped in exon 1 of ZSG where an acceptor splice site is created allowing an in frame fusion to a donor splice site in EWS intron 8. We were able to clone and sequence the 1 kb region surrounding the breakpoint from genomic tumor DNA (Figure 2c ).
Southern blot re-hybridization with a cDNA probe of the cloned ZSG sequence revealed two abnormal restriction fragments one of which comigrated with the A BAC library screening was performed by hybridization with ZSG cDNA probe by Research Genetics (Huntsville, AL, USA). Clones have been veri®ed by Southern hybridization prior to sequencing and positive BACs were used for FISH analysis. Unexpectedly, the chromosomal localization of ZSG on normal metaphase spreads resulted at band q12 of chromosome 22 (Figure 1d ), a site apparently indistinguishable from EWS gene localization. Double color FISH showed that the two genes colocalized ( Figure  1d ). Blast search against the recently available chromosome 22q sequences (Dunham et al., 1999) showed that ZSG gene is located 2 Mb distal to EWS and is transcribed in opposite orientation telomeric to centromeric. Thus a paracentric inversion of 22q12 should have occurred in order to create the active EWS-ZSG fusion gene. Since we could not detect the reciprocal ZSG-EWS fusion rearrangement either in tumor DNA by Southern blot hybridization and genomic PCR or by RT ± PCR (not shown), the translocation t(1;22) detected in the tumor karyotype could represent a secondary event disrupting the reciprocal ZSG-EWS hybrid gene as hypothesized for other fusion genes created by complex variant chromosomal rearrangements (Raynaud et al., 1996) . Alternatively, the translocation might harbor the microinversion leading to the EWS-ZSG gene. However, the translocation could also represent the chromosomal mechanism of inactivation of the second ZSG rearranged allele observed in Southern blot hybridization. Since only few chromosomal spreads were obtained from the short-term culture of the tumor specimen, we could not perform further FISH experiments on tumor metaphases to discriminate between the hypothesized mechanisms.
Full-length cDNA of ZSG was cloned by dierent approaches: 5' RACE, cDNA library and database screening of ESTs and bioinformatic sequence analysis of PAC dJ400N23 (AC005003) clone containing ZSG. The gene consists of six exons and extends for 20 kb. Exon 1 is in part contained in a 2.8 kb CpG island with a G´C content of 68%. Thus promoter methylation could be a mechanism of transcription regulation of ZSG in tumors. The analysis of intron-exon boundaries, predicted by computational sequence analysis of PAC dJ400N23 sequence performed using NIX program at HGMP (http://www.hgmp.mrc.ac.uk/) was con®rmed by direct sequencing of BAC 86B10 DNA. Schematic representation of the genomic organization and deduced amino acid sequence of ZSG are indicated in Figure 3a ,b. Hybridization experiments on a Multiple Tissue Northern blot showed ubiquitous expression of ZSG (Figure 4a ). Two major transcripts of 3 and 4 kb are present due to the occurrence of two distinct 3' UTR as suggested by genomic sequence analysis and con®rmed by Northern blot. Furthermore, RT ± PCR experiments showed that exon 5 is subjected to alternative splicing and is either fully retained or completely or partially skipped due to the presence of an internal acceptor splice site (data not shown, Figure 5a ). The two major alternative splicing variants are used by the chimeric EWS-ZSG transcript in tumor cDNA as assayed by RT ± PCR using primers speci®c for each alternatively spliced transcript and sequence analysis of PCR products (Figure 4b ). The presence of all alternative splice variants in tumor cDNA implies that the chimeric product is in principle capable of interacting with a full spectrum of ZSG-speci®c DNA target sequences.
Northern blot hybridization of tumor mRNA with a probe speci®c for the longest transcript showed a 3.5 kb band corresponding to the chimeric EWS-ZSG mRNA and absent expression of the 4 kb wild type (wt) ZSG transcript that was expressed in the normal tissue of the patient (Figure 4c ). Absence of wt ZSG mRNA in tumor tissue supports the observation that the rearrangement of the second ZSG allele observed in Southern blot led to a complete loss of wt ZSG expression.
Analysis of ZSG amino acid sequence displayed a cluster of reiterated (four to six depending on the presence of exon 5) Cys 2 -His 2 zinc ®ngers at the C terminus whereas a POZ domain (also called BTB) was located at N-terminus (Figure 3c ). An A ± T hook DNA binding motif is located upstream the ®rst zinc ®nger; this motif is a minor groove tether usually cooperating with other DNA binding structures to play important roles in chromatin modeling and transcription regulation. It was ®rst described in the high Figure 1 (a) Chromosome G-banding showing the reciprocal translocation t(1;22) (p36;q12) from short-term cultures of tumor cells. FISH on metaphase spreads using chromosome 1 (b) and 22 (c) painting probes demonstrating fusions between chromosome 1 and 22, indicated by white arrowheads. Short-term cell culture of tumor cells chromosome harvesting, G-banding and FISH with painting probes were performed with standard methods as previously described (Sozzi et al., 1997) . (d) Dual color FISH on metaphase spreads from peripheral blood lymphocytes of a healthy male donor showing co-localization of signals derived from ZSG using biotin labeled BAC86B10 (green spots) and EWS using rhodamine labeled cosmid F7 (red spots) (Desmaze et al., 1994) at 22q12. Probes were labeled by nick translation method according to the supplier's recommendations (Boehringer Mannheim). Bicolor FISH was performed as described (Desmaze et al., 1994) mobility group non-histone chromosomal proteins HMG-I(Y) and subsequently in many other DNA binding proteins from eukaryotic organisms (Aravind and Landsman, 1998) . The Poz domain is thought to function as a site for protein-protein interaction and is required for transcriptional repression of several genes, whereas the zinc-®ngers comprise a DNA binding domain (Chen et al., 1995; Deweindt et al., 1995) . Thus ZSG protein has the typical features of a transcription factor possibly acting as a repressor of gene expression as suggested by multiple alignment showing signi®cant similarity to two zinc ®nger proteins with oncogenic function PLZF (Chen et al., 1994) and BCL-6 (Wong and Privalsky, 1998) ( Figure 3d ). Of interest another zinc ®nger involved in transcriptional repression is WT1 (Madden et al., 1991) which is also fused to EWS Figure 2 (a) Southern blot analysis of BamHI (left) and EcoRI (right) digested genomic DNA from tumor (lane C) and normal tissues (lanes 1 ± 6). The same ®lter was hybridized with a 593 bp fragment corresponding to exons 7 ± 12 of the EWS cDNA (upper panel) and ZSG cDNA probe downstream the breakpoint (S2FN-S1R) (lower panel). Tumor DNA showed a rearranged band (black arrowheads) in addition to the germ-line bands with both probes. The ZSG probes downstream (lower panel) and upstream (not shown) the breakpoint both recognized an additional rearranged band in tumor DNA (white arrowhead). For Southern blot analysis DNA (10 mg) from primary tumor and normal tissues was digested with BamHI and EcoRI and then processed following standard methods (Maniatis et al., 1982) . Filters were incubated o.n. at 658C in hybridization solution consisting of 56SSPE, 56Denhardt's solution, 1% SDS, 0.1 mg/ml salmon sperm DNA. We washed the ®lters at 658C twice in 26SSC-0.5% SDS and twice in 0.16SSC-0.5% SDS. The following cDNA probes were used: (7) a 593 bp fragment corresponding to exons 7 ± 12 of the EWS gene (EWS720F-EWS1313R); (±) a 224 bp fragment of exon 1 of the ZSG gene included in the fusion transcript (S2FN-S1R). (Gerald et al., 1995) generating a chimeric product resembling EWS-ZSG. In common with our tumor, DSRCT shows a decreased immunoreactivity for MIC2 protein, a hallmark of the pPNET family of tumors (Gerald et al., 1998) . Moreover, DSRCT may occasionally display variant fusion transcripts. (Katz et al., 1997; Ordi et al., 1998) . Zinc ®nger domains of ZSG have a high level of similarity (Blastp E-value of le-70) with human myc-associated zinc ®nger protein (MAZ, P56270), a transcription factor that binds to c-MYC promoter and regulates transcription initiation and termination (Bossone et al., 1992) .
ZSG is the tenth fusion partner of EWS observed in sarcoma. In each case the N-terminal domain of EWS contributes to a strong transcription activation domain. Given the features of ZSG, its fusion with EWS, removing the putative transcriptional repressor domain at the N-terminus of ZSG, might convert a transcriptional repressor into an activator. A rearrangement of the second ZSG allele and lack of wt ZSG expression were also found in tumor cells suggesting loss of function of wt ZSG gene that thus may act as a classical tumor suppressor gene. The chimeric product is predicted to modulate the transcription at ZSG target sites, and contribute to development of this variant sarcoma phenotype with multiphenotypic dierentiation. Dierent alterations of a single gene in the same cell could thus provide an oncogenic activation (EWS-ZSG fusion) and the inactivation of a putative tumor suppressor gene, a model already suggested for acute lymphoblastic leukemia with TEL-AML1 fusion gene (Raynaud et al., 1996) . This is the ®rst example of an intra-chromosomal rearrangement of chromosome 22, otherwise undetectable by cytogenetics, activating EWS in soft tissue sarcoma. Considering that the creation of fusion genes with common partners is involved in sarcoma and leukemia (Rabbits, 1994) and that chromosomal region 22q12 suers loss of heterozygosity in a variety of solid tumors (Cheng et al., 1999; Klamt et al., 1998; Shiseki et al., 1994) , a broader involvement of ZSG in cancer might be envisaged.
Note added in proof
Very recently the short isoform of ZSG was isolated as a RNF4 interacting proteins acting as a transcriptional repressor (Fedele et al., 2000) . Figure 4 (a) Northern blot analysis of ZSG expression in multiple human adult tissues (MTN, Clontech) with probe S2FN-S1R located in exon 1 showing ubiquitous expression of the two transcripts of 4 and 3 kb, respectively, corresponding to the two ZSG isoforms. Size marker in kb is indicated on the left. Exposure time was 2 days at 7808C. (b) RT ± PCR analysis of the chimeric EWS-ZSG transcripts in tumor cDNA. An ampli®cation product was detected by using primer EWS 720 and primers S5R and A1R, respectively, speci®c for each alternatively spliced transcripts. One microgram of total RNA was retrotranscribed with Superscript II Rnase H 7 Reverse Transcriptase (Life Tech.) using random primers. One twentieth of the reaction was used for ampli®cation. All PCR ampli®cations were performed in 1.5 mM MgCl 2 , 0.2 mM dNTPs, 0.5 mM of each primer, 0.6 U AmpliTaqGold (Perkin Elmer), 16Reaction buer, on a 9700 PCR system (Perkin Elmer). 5'-TGGGCAACCGAGCAGCTATGGAC-3' 8F 5'-GTGGAGGCATGAGCAGAGGTG-3' 1313R 5'-TGGCAGTGGGTGGGTCTTCATAGG-3' ZSG S5R 5'-GTCAGGAACCGAATGGGACGA-3' A1R 5'-GCAGGGCACCTTGTCTTCATG-3' S2PR 5'-CATTGAGTCCAGCAGGTTGGCC-3' S2FN 5'-CCAACCTGCTGGACTCAATG-3' S1R 5'-CTCTTTCGGGGGCCGTCG-3' RaceIIR 5'-GTCGCCTACCCGCAAGAGCACG-3' (c) Northern blot analysis of ZSG in normal lung parenchyma and tumor tissue from the patient (lanes 3, 4), normal lung (lane 2) and lung cancer cell line H460 (lane 1). Hybridization with EST AI633731 (gi4685061) insert probe specific for the longest transcript shows a normal size (4 kb) transcript in the normal tissue and an abnormal transcript of 3.5 kb in tumor tissue of the patient (pt). A normal size transcript is present in all the other samples. RNA ladder 0.24 ± 9.5 kb (Gibco, BRL) is indicated on the left. Exposure time was 2 days at 7808C. Total RNA was isolated from primary tumor sample, normal tissues and cell lines by RNAzol B method (Tel-Test, Inc.) . Twenty micrograms of total RNA from tumor and normal samples were used for Northern blot analysis performed using standard conditions (Maniatis et al., 1982) . We hybridized filters and the Multiple Tissue Northern blot (Clontech) using the ExpressHyb Hybridization Solution (Clontech) according to user manual Oncogene A novel zinc finger gene fused to EWS in sarcoma T Mastrangelo et al
